Auna (AUNA) Competitors

$8.50
-0.05 (-0.58%)
(As of 09:39 AM ET)

AUNA vs. LFMD, TVTX, EHAB, TSHA, OFIX, VYGR, WGS, FULC, KALV, and ALEC

Should you be buying Auna stock or one of its competitors? The main competitors of Auna include LifeMD (LFMD), Travere Therapeutics (TVTX), Enhabit (EHAB), Taysha Gene Therapies (TSHA), Orthofix Medical (OFIX), Voyager Therapeutics (VYGR), GeneDx (WGS), Fulcrum Therapeutics (FULC), KalVista Pharmaceuticals (KALV), and Alector (ALEC). These companies are all part of the "medical" sector.

Auna vs.

LifeMD (NASDAQ:LFMD) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings.

LifeMD presently has a consensus target price of $11.60, indicating a potential upside of 50.26%. Auna has a consensus target price of $14.15, indicating a potential upside of 65.50%. Given LifeMD's higher possible upside, analysts clearly believe Auna is more favorable than LifeMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Auna
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, LifeMD had 4 more articles in the media than Auna. MarketBeat recorded 6 mentions for LifeMD and 2 mentions for Auna. Auna's average media sentiment score of 0.28 beat LifeMD's score of 0.20 indicating that LifeMD is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeMD
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Auna
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Auna has lower revenue, but higher earnings than LifeMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$152.55M2.17-$20.60M-$0.74-10.58
AunaN/AN/AN/AN/AN/A

35.5% of LifeMD shares are held by institutional investors. 18.9% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Auna has a net margin of 0.00% compared to Auna's net margin of -14.75%.

Company Net Margins Return on Equity Return on Assets
LifeMD-14.75% N/A -49.23%
Auna N/A N/A N/A

LifeMD received 22 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 70.27% of users gave LifeMD an outperform vote.

CompanyUnderperformOutperform
LifeMDOutperform Votes
26
70.27%
Underperform Votes
11
29.73%
AunaOutperform Votes
4
100.00%
Underperform Votes
No Votes

Summary

LifeMD beats Auna on 7 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AUNA vs. The Competition

MetricAunaOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$628.32M$661.47M$5.08B$18.02B
Dividend YieldN/AN/A36.65%3.43%
P/E RatioN/A24.00119.3822.09
Price / SalesN/A1.172,403.8410.22
Price / CashN/A71.5835.8420.16
Price / BookN/A39.635.796.01
Net IncomeN/A-$189.18M$104.88M$965.93M
7 Day Performance-10.34%-0.51%2.56%1.54%
1 Month Performance13.33%-11.29%4.81%6.71%
1 Year PerformanceN/A16.09%7.10%21.93%

Auna Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
1.5443 of 5 stars
$9.32
+0.2%
$11.60
+24.5%
+333.7%$508.65M$152.55M-13.31207Short Interest ↑
High Trading Volume
TVTX
Travere Therapeutics
1.1459 of 5 stars
$6.30
-4.5%
$16.69
+165.0%
-59.4%$498.51M$145.24M-3.00380Gap Up
EHAB
Enhabit
3.0071 of 5 stars
$8.33
+0.5%
$11.21
+34.6%
-29.7%$494.54M$1.05B-5.1410,800Analyst Upgrade
Analyst Revision
News Coverage
Gap Up
High Trading Volume
TSHA
Taysha Gene Therapies
2.1487 of 5 stars
$2.34
-7.5%
$6.88
+193.8%
+353.8%$489.99M$15.45M-3.4952Earnings Report
Analyst Forecast
Analyst Revision
OFIX
Orthofix Medical
0.7546 of 5 stars
$14.64
+1.0%
$18.00
+23.0%
-16.9%$503.49M$746.64M-3.541,634
VYGR
Voyager Therapeutics
3.8242 of 5 stars
$8.44
flat
$19.60
+132.2%
-24.1%$486.23M$250.01M2.73162Analyst Forecast
Analyst Revision
WGS
GeneDx
1.4805 of 5 stars
$20.75
+2.1%
$18.00
-13.3%
+280.7%$509.91M$202.57M-4.011,000Insider Buying
Positive News
Gap Up
FULC
Fulcrum Therapeutics
2.7248 of 5 stars
$7.47
-0.4%
$13.17
+76.3%
+105.1%$481.69M$2.81M-4.7376Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
KALV
KalVista Pharmaceuticals
4.1863 of 5 stars
$12.08
-0.1%
$25.00
+107.0%
+20.1%$512.17MN/A-3.83118
ALEC
Alector
3.4794 of 5 stars
$5.25
+1.0%
$14.00
+166.7%
-27.9%$512.77M$97.06M-3.39244Short Interest ↑

Related Companies and Tools

This page (NYSE:AUNA) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners